David Cooper, Meena Upadhhyaya
Facioscapulohumeral Muscular Dystrophy (FSHD)
Clinical Medicine and Molecular Cell Biology
David Cooper, Meena Upadhhyaya
Facioscapulohumeral Muscular Dystrophy (FSHD)
Clinical Medicine and Molecular Cell Biology
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This volume summarizes the current understanding of the disorder, including clinical, molecular and therapeutic aspects.
Andere Kunden interessierten sich auch für
- Muscular Dystrophy124,99 €
- Mari C SchuhMia's Mighty Muscular System31,99 €
- Muscular Dystrophies91,99 €
- Francis Gano BenedictMuscular Work27,99 €
- Graham HoyleComparative Physiology of the Nervous Control of Muscular Contraction35,99 €
- Rebecca L JohnsonYour Muscular System34,99 €
- Rui DiogoMuscular and Skeletal Anomalies in Human Trisomy in an Evo-Devo Context254,99 €
-
-
-
This volume summarizes the current understanding of the disorder, including clinical, molecular and therapeutic aspects.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 420
- Erscheinungstermin: 22. April 2004
- Englisch
- Abmessung: 240mm x 161mm x 27mm
- Gewicht: 793g
- ISBN-13: 9781859962442
- ISBN-10: 1859962440
- Artikelnr.: 21051409
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
- Verlag: Taylor & Francis
- Seitenzahl: 420
- Erscheinungstermin: 22. April 2004
- Englisch
- Abmessung: 240mm x 161mm x 27mm
- Gewicht: 793g
- ISBN-13: 9781859962442
- ISBN-10: 1859962440
- Artikelnr.: 21051409
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
David Cooper
1. Introduction and Overview of FSHD. 2. Facioscapulohumeral Muscular
Dystrophy: Historical Background and Literature Review. 3.
Facioscapulohumeral Muscular Dystrophy: A Clinician's Experience. 4.
Mapping of the FSHD Gene and the Discovery of the Pathognomonic Deletion.
5. Identification and Characterization of Candidate Genes in FSHD Region.
6. Evolution of Structural Organization of the Homeobox-Containing Repeat
D4Z4. 7. Subtelomeric Exchange Between 4q and 10q Sequences. 8. Genomic
Analysis of the Subtelomeric Regions of Human Chromosomes 10q and 4q:
Relevance to FSHD. 9. The DUX Gene Family and FSHD. 10. Facioscapulohumeral
Muscular Dystrophy (FSHD): A disorder of Muscle Gene Repression. 11.
Genotype-Phenotype Relationships in FSHD. 12. Mosaicism and FSHD. 13.
Retinal Vascular Abnormalities in FSHD: A Therapeutic Message; Clues to
Pathogenesis. 14. Unusual Clinical Features Associated with FSHD. 15.
Molecular Diagnosis of FSHD.16. FSHD Myoblasts: in vitro Studies. 17.
Exploring Hypotheses about the Molecular Aetiology of FSHD: Loss of
Heterochromatin Spreading and other Long-range Interaction models. 18.
Histological, Immunological, Molecular and Ultrastructural Characteristics
of FSHD Muscle. 19. Linkage Analysis in Non-Chromosome 4-Linked FSHD. 20.
Facioscapulohumeral Muscular Dystrophy: Gender Differences and Genetic
Counselling in a Complex Disorder. 21. Genetic Counseling for
Facioscapulohumeral Muscular Dystrophy (FSHD). 22. Sarcolemmal
Reorganization in FSHD. 23. Expression Profiling in FSHD. 24. Therapeutic
Trials and Medical Management in FSHD.
Dystrophy: Historical Background and Literature Review. 3.
Facioscapulohumeral Muscular Dystrophy: A Clinician's Experience. 4.
Mapping of the FSHD Gene and the Discovery of the Pathognomonic Deletion.
5. Identification and Characterization of Candidate Genes in FSHD Region.
6. Evolution of Structural Organization of the Homeobox-Containing Repeat
D4Z4. 7. Subtelomeric Exchange Between 4q and 10q Sequences. 8. Genomic
Analysis of the Subtelomeric Regions of Human Chromosomes 10q and 4q:
Relevance to FSHD. 9. The DUX Gene Family and FSHD. 10. Facioscapulohumeral
Muscular Dystrophy (FSHD): A disorder of Muscle Gene Repression. 11.
Genotype-Phenotype Relationships in FSHD. 12. Mosaicism and FSHD. 13.
Retinal Vascular Abnormalities in FSHD: A Therapeutic Message; Clues to
Pathogenesis. 14. Unusual Clinical Features Associated with FSHD. 15.
Molecular Diagnosis of FSHD.16. FSHD Myoblasts: in vitro Studies. 17.
Exploring Hypotheses about the Molecular Aetiology of FSHD: Loss of
Heterochromatin Spreading and other Long-range Interaction models. 18.
Histological, Immunological, Molecular and Ultrastructural Characteristics
of FSHD Muscle. 19. Linkage Analysis in Non-Chromosome 4-Linked FSHD. 20.
Facioscapulohumeral Muscular Dystrophy: Gender Differences and Genetic
Counselling in a Complex Disorder. 21. Genetic Counseling for
Facioscapulohumeral Muscular Dystrophy (FSHD). 22. Sarcolemmal
Reorganization in FSHD. 23. Expression Profiling in FSHD. 24. Therapeutic
Trials and Medical Management in FSHD.
1. Introduction and Overview of FSHD. 2. Facioscapulohumeral Muscular
Dystrophy: Historical Background and Literature Review. 3.
Facioscapulohumeral Muscular Dystrophy: A Clinician's Experience. 4.
Mapping of the FSHD Gene and the Discovery of the Pathognomonic Deletion.
5. Identification and Characterization of Candidate Genes in FSHD Region.
6. Evolution of Structural Organization of the Homeobox-Containing Repeat
D4Z4. 7. Subtelomeric Exchange Between 4q and 10q Sequences. 8. Genomic
Analysis of the Subtelomeric Regions of Human Chromosomes 10q and 4q:
Relevance to FSHD. 9. The DUX Gene Family and FSHD. 10. Facioscapulohumeral
Muscular Dystrophy (FSHD): A disorder of Muscle Gene Repression. 11.
Genotype-Phenotype Relationships in FSHD. 12. Mosaicism and FSHD. 13.
Retinal Vascular Abnormalities in FSHD: A Therapeutic Message; Clues to
Pathogenesis. 14. Unusual Clinical Features Associated with FSHD. 15.
Molecular Diagnosis of FSHD.16. FSHD Myoblasts: in vitro Studies. 17.
Exploring Hypotheses about the Molecular Aetiology of FSHD: Loss of
Heterochromatin Spreading and other Long-range Interaction models. 18.
Histological, Immunological, Molecular and Ultrastructural Characteristics
of FSHD Muscle. 19. Linkage Analysis in Non-Chromosome 4-Linked FSHD. 20.
Facioscapulohumeral Muscular Dystrophy: Gender Differences and Genetic
Counselling in a Complex Disorder. 21. Genetic Counseling for
Facioscapulohumeral Muscular Dystrophy (FSHD). 22. Sarcolemmal
Reorganization in FSHD. 23. Expression Profiling in FSHD. 24. Therapeutic
Trials and Medical Management in FSHD.
Dystrophy: Historical Background and Literature Review. 3.
Facioscapulohumeral Muscular Dystrophy: A Clinician's Experience. 4.
Mapping of the FSHD Gene and the Discovery of the Pathognomonic Deletion.
5. Identification and Characterization of Candidate Genes in FSHD Region.
6. Evolution of Structural Organization of the Homeobox-Containing Repeat
D4Z4. 7. Subtelomeric Exchange Between 4q and 10q Sequences. 8. Genomic
Analysis of the Subtelomeric Regions of Human Chromosomes 10q and 4q:
Relevance to FSHD. 9. The DUX Gene Family and FSHD. 10. Facioscapulohumeral
Muscular Dystrophy (FSHD): A disorder of Muscle Gene Repression. 11.
Genotype-Phenotype Relationships in FSHD. 12. Mosaicism and FSHD. 13.
Retinal Vascular Abnormalities in FSHD: A Therapeutic Message; Clues to
Pathogenesis. 14. Unusual Clinical Features Associated with FSHD. 15.
Molecular Diagnosis of FSHD.16. FSHD Myoblasts: in vitro Studies. 17.
Exploring Hypotheses about the Molecular Aetiology of FSHD: Loss of
Heterochromatin Spreading and other Long-range Interaction models. 18.
Histological, Immunological, Molecular and Ultrastructural Characteristics
of FSHD Muscle. 19. Linkage Analysis in Non-Chromosome 4-Linked FSHD. 20.
Facioscapulohumeral Muscular Dystrophy: Gender Differences and Genetic
Counselling in a Complex Disorder. 21. Genetic Counseling for
Facioscapulohumeral Muscular Dystrophy (FSHD). 22. Sarcolemmal
Reorganization in FSHD. 23. Expression Profiling in FSHD. 24. Therapeutic
Trials and Medical Management in FSHD.